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(57) ABSTRACT 
A simple and rugged sheathleSS interface for capillary 
electrophoresis/electrospray ionization-mass spectrometry 
(CE/ESI-MS) was designed using common laboratory tools 
and chemicals. The interface uses a Small platinum (Pt) wire 
which is inserted into the CE capillary through a small hole 
near the terminus. The position of the wire inside the CE 
capillary and within the buffer Solution is analogous to 
Standard CE Separation operations where the terminus of the 
CE capillary is placed inside a buffer reservoir along with a 
grounded platinum electrode. By combining the use of the 
in-capillary electrode interface with sharpening of the fused 
Silica tip of the CE capillary outlet, a stable electrospray 
current was maintained for an extended period of time. The 
design was successfully applied to CE/ESI-MS separations 
and analysis of mixtures of peptides and proteins. A detec 
tion limit of approximately 4 femtomole (S/N=3) was 
achieved for detection of myoglobin utilizing a 75 um-i.d. 
aminopropylsilane treated CE column and using a wide Scan 
range of 550-1350 Da. The advantages of this new design 
include: (1) a stable CE and ESI current, (2) durability, (3) 
a reduced risk of Sparking between the capillary tip and the 
inlet of the mass spectrometer, (4) lack of any dead volume, 
and (5) facile fabrication with common tools and chemicals. 
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SHEATHLESS INTERFACE FOR 
CAPILLARY ELECTROPHORESIS/ 
ELECTROSPRAY ONIZATION-MASS 
SPECTROMETRY USING AN IN-CAPLLARY 
ELECTRODE 
This is a continuation of co-pending application Ser. No. 
PCT/US98/02118, international filing date Feb. 5, 1998, 
which claims priority to U.S. Provisional Patent Application 
No. 60/036,922 filed Feb. 6, 1997. 
1.O. BACKGROUND OF THE INVENTION 
1.1 Field of the Invention 
The present invention relates generally to a new proceSS 
for the interfacing of capillary electrophoresis to mass 
Spectrometry via electrospray ionization. More particularly, 
it concerns a novel sheathleSS interface useful for capillary 
electrophoresis/electrospray ionization. 
1.2 Description of Related Art 
The combination of mass spectrometry (MS) with a 
high-efficiency Separation technique Such as capillary elec 
trophoresis (CE) provides a powerful System for the analysis 
of complex biological mixtures (William 1996). Currently, 
electrospray ionization (ESI) serves as the most common 
interface between CE and MS. A particularly important 
feature of any CE.-MS interface is the method used to 
establish and maintain the electrical connection at the CE 
capillary terminus. These connections Serve to close the CE 
electrical circuit and to provide a connection for the ESI 
Voltage. The methods used to maintain these connections 
can be divided in two general categories: sheath-flow inter 
faces and sheathleSS interfaces. Comprehensive reviews of 
current CE/ESI-MS interfaces have been described by Caiet 
al. (Cai and Henion 1995) and Severs et al. (Severs, et al. 
1996). 
The sheath-flow configuration has been the most widely 
used interface for CE/ESI-MS, especially in commercial 
instrumentation. Sheathed techniques include Smith and 
co-workers coaxial system (Smith et al. 1988) and the 
liquidjunction technique established by Lee and co-workers 
(Lee et al. 1989). Sheath-flow configurations have several 
advantages including Simple fabrication, reliability, and case 
of implementation. However, these techniques also bear 
Several disadvantages: (1) dilution of the analyte by the 
sheath liquid; (2) competition for available charge between 
the Species present in the sheath-flow and the analyte in the 
ESI process (Gale and Smith 1993); and (3) effects on 
Separation, Solubility, or molecular conformation which vary 
according to sheath liquid composition (Thompson et al. 
1993, Foret et al. 1994, Smith et al. 1991). 
In an attempt to remedy these problems, Severs et al. 
(1996) recently developed a new CE/ESI-MS interface in 
which the terminus of the CE Separation capillary and a short 
ESI emitter capillary are connected by poly Sulphone micro 
dialysis tubing. The electrical connection is provided outside 
the membrane via an electrode in a Small sheath liquid 
reservoir that Serves to close the CE circuit and Simulta 
neously establish the electrospray Voltage. 
The first successful sheathless coupling of CE with MS 
was reported by Olivares et al. (1987). In this initial work, 
the outlet of the CE capillary was terminated within a 
stainless steel capillary which functioned as both a CE 
electrode and the electrospray needle. In this configuration, 
however, there was a relatively large dead volume at the 
capillary terminus. The current version of the sheathleSS 











Wahl and Smith (1994) presented a somewhat similar 
CE-MS interfacing approach, however, the electrical con 
nection to the end of Separation capillary was made though 
a micro-hole 2 cm from the end of the CE column. The 
micro-hole was Sealed by conductive gold epoxy, through 
which electrical contact was made. Results presented by the 
inventors laboratory (Cao and Moini 1995) and others show 
that these types of designs increase Sensitivity by avoiding 
dilution of the sample with the sheath liquid. However, the 
CE capillaries made with the conductive gold tip or with the 
conductive gold epoxy have a short lifetime due to degra 
dation of the gold tip or conductive gold contact as a result 
of chemical, electrochemical, and/or electrical phenomena. 
This degradation is a gradual proceSS which interrupts 
electrical contact to the CE terminus leading to changes in 
migration times, instability of the CE current, and an 
unstable electrospray (Wahl and Smith 1994). 
Another approach to sheathless CE-MS coupling is that of 
Fang et al. (1994) in which electrical contact to the CE 
capillary terminus is made by inserting a platinum wire into 
the outlet of the CE column. While an advantage of this 
technique is its ruggedness, however, there are two disad 
Vantages associated with this method: the potential of arcing 
between the wire at the CE outlet and the inlet of the mass 
Spectrometer and a non-uniform Spray at the CE capillary 
terminus. 
2O SUMMARY OF THE INVENTION 
The present invention concerns a new sheathless CE/ESI 
interface which utilizes the advantages of previous tech 
niques While eliminating many of the disadvantages, par 
ticularly in providing a rugged and durable interface that is 
currently not available. Presently used interfaces do not 
allow for routine analyses and are limited in use to highly 
Sophisticated research laboratories. The interface of the 
present invention retains Sensitivity and functional advan 
tages of the CE/ESI-MS system while providing the advan 
tage of withstanding the repositioning and manipulation of 
the interface required in optimizing measurements. 
A new feature of this interface is the placement of the 
electrode wire inside of the CE capillary through a hole in 
the CE capillary wall. Previous designs of the CE/ESI-MS 
interface can be divided into two categories, sheathed and 
sheathleSS. In the sheathed designs, the electric contact to the 
CE capillary terminus is established by contact between the 
sheath liquid and the liquid content of the CE capillary at the 
terminus. This type of interface is represented by a coaxial 
sheath flow interface developed by Smith and co-workers 
(1988; 1991). Several sheathless interface designs have been 
utilized each with its own unique properties: (1) the low 
Voltage end of the CE capillary was terminated within a 
Stainless Steel capillary as reported by Olivares and 
co-workers; (2) a gold conductive coating at the CE capil 
lary terminus to establish electrical contact with the CE 
effluents developed by Wahl, et al.; (3) Zare and co-workers’ 
design established electrical contact with the effluents at the 
ESI end of the CE capillary by inserting a platinum wire into 
the opening of the capillary terminus; (4) more recently, 
Joanne and co-workerS developed an interface in which the 
terminus of the CE capillary and a short ESI emitter capil 
lary are connected and sheathed by polysulphone micro 
dialysis tubing. The disclosed sheathless interface differs 
from other technology in appearance and function. 
The design of the disclosed interface has Several advan 
tages over previous designs. First, the design is more durable 
than other designs. The platinum wire is Securely fastened 
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within the capillary and can, therefore, withstand much more 
repositioning and movement than previous designs could 
without breaking. Next, the design affords a stable CE 
current Since electrical contact is established by way of a 
wire rather than by way of a sheath liquid. This advantage 
allows for the best possible CE separation. Additionally, the 
design has no dead volume within the interface. This ensures 
the best resolution from the CE separation whereas most 
designs have dead volume which leads to peak broadening. 
Finally, the design does not interfere with the electrospray 
proceSS Since the platinum wire does not enter through the 
CE capillary terminus as it does in other designs. 
3.O BRIEF DESCRIPTION OF THE DRAWINGS 
The following drawings form part of the present Specifi 
cation and are included to further demonstrate certain 
aspects of the present invention. The invention may be better 
understood by reference to one or more of these drawings in 
combination with the detailed description of Specific 
embodiments presented herein. 
FIG. 1A schematic of the in-capillary electrode interface 
for CE/ESI-MS, showing the end (outlet) of the CE column. 
FIG. 2 Total ion electropherogram of a protein mixture 
using the in-capillary electrode CE/ESI-MS sheathless inter 
face. A, gramicidin S; B, myoglobin, and C, cytochrome c. 
Unmarked peaks were not identified. 
FIG. 3 CE/ESI-MS spectra corresponding to the peaks of 
FIG. 2. FIG. A., gramicidin S, FIG. B., myoglobin; and FIG. 
C, cytochrome c. 
FIG. 4 Comparison between the UV electropherograms of 
a peptide mixture (standard C) using a 75 um i.d., 80 cm 
long capillary (50 cm to UV): one (A) without in-capillary 
electrode, and the other one (b) with in-capillary electrode. 
1, GY; 2, methionine enkephalin; 3, leucine enkephalin; 4, 
VYV; and 5, angiotensin II. 
FIG. 5 The effect of methanol on the integrity of the 
epoxy. (A) 0.01 Macetic acid. (B) 0.01 Macetic acid with 
10% methanol. 
FIG. 6 The effect of the pH of the acetic acid buffer on 
CE/ESI-MS performance. (A), pH 2.0; (B), pH 3.4; (C), pH 
5.0. 1, AESE; 2, FV; 3, morphiceptin; 4, VHLTPVEK; 5, 
bradykinin, and 6, cytochrome c. 
FIG. 7 A comparison between CE/ESI-MS performance 
obtained using 50 um i.d. (A) 30 um i.d., and (B) APS 
treated CE capillaries. 
FIG. 8 Total ion electropherogram of protein standard D 
using the in-capillary electrode CE/ESI-MS sheathless inter 
face. 1, B-lactoglobulin A; 2, ribonuclease A, 3, myoglobin; 
4, lysozyme, 5, cytochrome c. 
FIG. 9 CE/ESI-MS spectra corresponding to the peaks of 
FIG. 8. (A), B-lactoglobulin A; (B), ribonuclease A, (C), 
myoglobin, (D), lysozyme; (E), cytochrome c. 
FIG. 10 The total ion electropherograms obtained from 
tryptic digests of horse heart cytochrome c (A) and myo 
globin (B). See TABLES 1 and 2 for the m/z and sequence 
of each peak. *, unidentified peaks. 
FIG. 11 CE/ESI-MS analysis of red blood samples. Injec 
tions of approximately (A), 10 pmol; (B), 1 pmol; (C), 100 
fmole; (D), 10 fmole. 
FIG. 12 Mass spectra of C. and B, hemoglobin correspond 
ing to the peaks of FIG. 12C. (A), C. hemoglobin, (B), B 
hemoglobin, and *, unidentified peaks. 
FIG. 13 Reconstructed ion electropherograms (RIE) of 











and myoglobin (B) using CE/ESI-TOF-MS. Peaks marked 
with * and ** represent the reference compounds, Ultramark 
1621 and MRFA, respectively. 
FIG. 14 Tandem mass spectrum of a 14-residue peptide, 
TGQAPGFTYTDANK, using an in-source CID showing an 
intense Y" fragment ion series. Peaks marked with * were 
due to the co-eluting peptide m/z 964.529 and its CID 
fragments. 
FIG. 15 CE/ESI-MS of the selected ion electrophero 
grams of a peptide mixture under different programmed 
preSSures using the Single ion monitoring mode. Experimen 
tal conditions: A, -30 kV and 0.5 psi pressure; B, -30 kV, 
pressure maintained at 0.5 psi for the first 22 minutes then 
ramped to a final preSSure of 3.8 psi at a rate of 0.6 psi/min, 
C, -30 kV, the pressure increased from 0 to 2.0 psi at a rate 
of 0.33 psi/min for the first 6 minutes, maintained at 2.0 psi 
for 9 minutes, then ramped to 4.0 psi at a rate of 0.72 
psi/min. Other conditions: 
-10 kV electrokinetic injection with a duration of 5 
Seconds, a 1 10 cm long, 75 -um-i.d., 150 um O.d. CE 
capillary; an acetic acid buffer (0.01 M, pH 3.2); CE 
inlet voltage -30 kV, electrospray voltage +3.5 kV. A., 
Leu-gly; B, Val-asp; C, Phe-val; 
D, Leu-phe; E, Gramicidin S. 
FIG. 16 Total ion electropherograms (TIE) of the tryptic 
digest fragments of hemoglobin S using CE/ESI-TOF-MS. 
Peaks marked with * and * * represent the reference 
compounds, AGSE and MRFA, respectively. See TABLE 6 
for the m/z and the Sequence of each peak. 
FIG. 17 Calibrated mass spectra of the peak 16 in FIG. 16 
which corresponds to the VHLTPVEK, the eight N-terminal 
residue peptide of HbS. 
FIG. 18 Tandem mass spectrum of a 8-residue peptide 
(VHLTPVEK, the eight N-terminal residue peptide of HbS), 
using an in-Source CID showing an intense Y" fragmention 
Series. 
31 BRIEF DESCRIPTION OF THE TABLES 
TABLE 1. 
Tryptic Digests of Horse Cytochrome c in the m/z Range 
of 500–1000. Acetyl-DVEKGKKIFVOKCAQCHTVEK 
(heme)GGKHKTGPNLHGLFG RKTGQAPGFTYT 
DANKNKGITWKEET L MEY LEN PKKY 
IPGTKMIFAGIKKK TEREDLIAYLKKATNE (SEQ ID 
NO: 1) (104 amino acids, MW=12359.8 Da). 
TABLE 2 
Tryptic Digests of Horse Heart Myoglobin in the m/z. 
Range of 500-1000. GLSDGEWOOVLNVWGKVEADI 
AGH G O EV LIRLF TG HPETLE KFD KF KHL KT 
EAEMKASE DLKKHGTV VLTALG 
GILKKKGHHEAELKPLAOSHATKHKIPIK YLEFIS 
DAIIHVLHSKH P G D F GADAO GAMT 
KALELFRNDIAAKYKELGFQG (SEQ ID NO: 2) (153 
amino acids, MW=16951.5 Da). 
TABLE 3 
Measured masses of tryptic digests of horse cytochrome 
c in the m/z range of 500-1000. Acetyl 
GDVEKGKKIFVQKCAQCHTVEK(heme) GGKHKTGP 
NLHGLF GRKTGOAPGFTYTDANKNKGITW 
KEETLME YLE NPKKYIP GTKM IFAG IKK 
KTEREDLIAYLKKATNE (SEQ ID NO: 3) (104 amino 
acids, calculated average MW 12359.80 Da). 
TABLE 4 
Measured masses of tryptic digests of horse heart myo 
globin in the m/z range of 500–1000. GLSDGEWOQVL 
N VW GK VE ADI AG H G O EV LIRLFTG H 
PETLE KF DK FKHLKT 
US 6,863,790 B1 
S 
EAEMKASE DLKKHGTV VLTALG 
GILKKKGHHEAELKPLAOSHATKHKIPIK YLEFIS 
DAIIHVLIHSKH P G D F GADAO GAMT 
KALELFRNDIAAKYKELGFQG (SEQ ID NO: 4) (153 
amino acids, calculated average MW 16951.53 Da). 
TABLE 5 
Measured masses of the collisionally induced fragments 
of tryptic digests of cytochrome c in the m/z range of 
350-1500 using in-source fragmentation. 
TABLE 6 
Measured masses of tryptic digests of hemoglobin S in the 
m/z range of 350–1500. 
4.O DESCRIPTION OF ILLUSTRATIVE 
EMBODIMENTS 
The following examples are included to demonstrate 
preferred embodiments of the invention. It should be appre 
ciated by those of skill in the art that the techniques 
disclosed in the examples which follow represent techniques 
discovered by the inventor to function well in the practice of 
the invention, and thus can be considered to constitute 
preferred modes for its practice. Moreover, all of the meth 
ods and apparatus disclosed and claimed herein can be made 
and executed without undue experimentation. However, 
those of skill in the art should, in light of the present 
disclosure, appreciate that many changes can be made in the 
Specific embodiments which are disclosed and Still obtain a 
like or Similar result without departing from the Spirit and 
Scope of the invention. 
5.0 EXAMPLES 
5.1 Example 1 
Materials and Methods 
In a first reduction to practice of the present invention, CE 
capillary columns were prepared from 75 um-i.d., 150 
alm-o.d. capillary columns (Polymicro Technology, Phoenix, 
Ariz.). A microscope (0.7 to 4.2x) (AO Instrument 
Company, Buffalo, N.Y.) was used for construction of the 
capillary. The fabrication procedure was as follows. 
A 50 um-diameter platinum (Pt) wire (Goodfellow, 
Berwyn, Pa.) was inserted approximately 4 cm inside one 
end of the CE column, hereafter called the CE outlet (as 
opposed to the inlet). Using a 2.22 cm-diameter abrasive 
disk (Small Parts Inc., Miami Lakes, Fla.) attached to a drill 
(DREMEL, Racine, Wis.), a small opening was made into 
the wall of the column approximately 2 cm from the CE 
outlet. Preliminary data indicated no noticeable difference in 
results when the hole was made in the range of 1.5-2.5 cm 
from the CE outlet. The 50 tum-diameter Pt wire prevented 
the capillary from breaking during the cutting process. 
After the opening was made, the 50 um-diameter Pt wire 
was retracted (approximately 2.5 cm) until it was slightly 
beyond the new opening. A 25 lim-diameter Pt wire was 
inserted 0.2-0.3 cm into the column through the cut. The 50 
lim-diameter Pt wire was then slowly pushed back into the 
capillary, passing the opening by about 0.3 cm, bending the 
25um-diameter wire toward the inner wall (FIG. 1). The cut 
was then Scaled using epoxy (APS replacement adhesive, 
Mecum Group, Waltham, Mass.), thereby securing the 25 
tum-diameter wire in place. The 50 lim-diameter wire pre 
vented the epoxy from penetrating into the CE column and 
clogging the column. After about five minutes, while the 
epoxy was still flexible, the 50 tum-diameter wire was very 
carefully drawn completely out of the column. To ensure the 
CE capillary remained unclogged, nitrogen gas was passed 











Using a flame, 0.5 cm of the outside polyimide coating at 
the terminus of the capillary was removed. To Sharpen the tip 
of the CE column, the exposed fused Silica portion of the tip 
was etched with a 50% hydrofluoric acid (HF) solution for 
about 15 minutes. Helium gas was passed though the column 
during the etching process to minimize enlargement of the 
CE outlet. 
A similar CE capillary was also prepared with a gold 
coated tip using a Sputter deposition System (Materials 
Research Corporation, Orangeburg, N.Y.). 
It has been determined in Subsequent experiments that 1 
lum to 10 um Pt wires may also be used for the electrode 
inside the CE capillary column. Moreover, CE capillary 
columns having Smaller i.d.S, Such as 50 um and 30 um may 
also be used. In fact, Smaller i.d. capillary columns offer 
certain advantages over the larger i.d. capillary columns as 
will be discussed in detail Subsequently. Generally, narrower 
capillaries enhance the Sensitivity of detection in sheathleSS 
CE-MS interfaces. It should be noted that as Smaller i.d. 
capillaries are used in practicing the invention, the diameter 
of the electrode should also be reduced So that the presence 
of the electrode inside the capillary column does not clog the 
column. The diameter of the electrode should be at least 
Smaller in diameter than the i.d. of the capillary column, and 
preferably as Small as practicable. 
For the CE Separations of Small peptides, a 45 cm-long 
capillary was used in which the inner wall was chemically 
modified with aminopropylsilane (APS) according to the 
procedure of Figeys et al. (1996). This procedure, however, 
did not produce adequate Separation for large peptides and 
for proteins. For these analyses, a longer column (80 cm) 
was used in which the inner wall of the CE capillary was 
derivatized using the APS derivatization procedure devel 
oped by Moseley et al. (1992). For the studies presented 
here, the chemical modifications were performed prior to the 
insertion of the Pt wire. The APS derivatization following Pt 
wire insertion has also been performed, but within combined 
experimental errors, the difference in results were insignifi 
Cant. 
As a result of the APS Surface modification and the acidic 
buffer Solution used, the inner wall of the capillary has a net 
positive charge. This results in an electrooSmotic flow in the 
opposite direction of uncoated fused-Silica capillaries. 
Therefore, for Small peptides, electrophoresis was per 
formed at an applied potential of -278 V/cm (–9.0 kV at the 
CE capillary inlet and +3.5 kV at the electrospray terminus). 
For protein analysis, the applied potential for the CE Sepa 
ration was -288 V/cm (–20.0 kV at the CE capillary inlet 
and +3.0 kV at the CE electrospray terminus). The buffer 
Solution (0.01 M acetic acid) was prepared using distilled 
water (Barnsted NANOpure II, Boston, Mass.) and acetic 
acid (Baxter Healthcare Corporation, McGaw Park, Ill.). 
Sodium hydroxide (NaOH), hydrochloric acid (HCl), and 
hydrofluoric acid (HF) solutions were purchased from Fisher 
Scientific Company (Fair Lawn, N.J.). Argon and helium 
gases were purchased from Wilson Oxygen & Supply Co., 
Inc. (Austin, Tex.). All other chemicals (including peptides, 
proteins, and APS) were purchased from Sigma Chemical 
Company (St. Louis, Mo.) and used without further purifi 
cation. All Solutions were filtered through a Syringe filter 13 
mm/0.5 um (Baxter Scientific, Grand Prairie, Tex.). The CE 
instrument used was a P/ACE System 2100 (Beckman 
Instruments, Fullerton, Calif., USA) operating with Beck 
man System Gold software. The running buffer for all CE 
Separations was a 0.01 M acetic acid aqueous Solution 
(pH=3.2). Prior to each set of measurements, the capillary 
was conditioned with the buffer for 5 minutes. For all sample 
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injections, the outlet of the CE capillary was held at ground 
potential. The ESI interface used for these studies was built 
in house (Jackett and Moini 1994) for a Finnigan MATTSQ 
70 mass spectrometer (San Jose, Calif.). 
5.2 Example 2 
Stability of Contact at CE. Terminus 
The stability and reliability of the electrical contact at the 
CE terminus is an important aspect for Successful electro 
phoresis. With the inventors design, electrical contact is 
reliably maintained by placing the electrode inside the CE 
capillary through a Small hole in the capillary wall near the 
terminus. This electrode acts both as the low Voltage elec 
trode of the CE electric circuit and as a connection for the 
electrospray ionization Voltage. 
The stability of the CE current was tested for the 
in-capillary electrode CE/ESI-MS sheathless interface uti 
lizing the column and parameters established above for 
Small peptide analysis. The CE current was stable at 2.5 uA 
+0.25 uA for 50 minutes (maximum time studied). 
Unlike other sheathless interfaces in which the CE cap 
illary tip either is gold coated or has a wire that is inserted 
into the outlet of the CE capillary, with the inventors 
in-capillary electrode design, stable CE and electrospray 
currents were achieved over long periods by Simply sharp 
ening the fused silica tip of the CE capillary. With no metal 
at the tip, one can place the capillary terminus much closer 
to the inlet of the mass spectrometer with minimal arcing 
possibility. 
The electrospray ion signal intensity of a column with a 
bare fused Silica tip was compared to that of a column with 
a gold-coated tip using the in-capillary electrode design for 
both columns. It was found that, within the experimental 
error, the intensities and stability of the ESI ion signals were 
Similar for both tips. Additionally, no noticeable background 
chemical noise due to direct contact between the epoxy and 
the electrolyte Solution was observed in the mass range 
Studied. Moreover, Since Some CE Separations require a CE 
buffer containing 10% methanol (Figeys et al. 1996), several 
CE/ESI-MS experiments were performed under this 
condition, and no sign of epoxy deterioration was observed. 
5.3 Example 3 
Performance Evaluation 
To evaluate the overall performance of the sheathless 
in-capillary electrode electrospray interface design, a mix 
ture containing three dipeptides (Val Asp, Phe Val, LeuPhe) 
and one eight residue peptide, ValHisLeuThrProValGluLys 
(0.1 mg/mL each peptide) was electrokinetically injected 
into the capillary using -5.0 kV potential difference acroSS 
the capillary with a duration of 5 Seconds. All compounds 
were resolved and detected in less than four minutes. The 
mass spectra of each peak of the electropherogram showed 
a protonated molecule as the base peak for the dipeptides 
and the doubly charged ion as the base peak for the eight 
residue peptide. 
For this experiment, the mass spectrometer was operated 
under a wide Scan mode (180-480 mass-to-charge (m/z), 1 
Sec/scan). 
The utility of this design for protein and peptide analysis 
was demonstrated by analysis of a mixture containing 0.25 
mg/mL myoglobin (MW=16,951 Dalton (Da)), cytochrome 
c (MW=12,360 Da), and gramicidin S (MW=1,141 Da) in 
HO+CH-OH+CHCOOH (47:47:6, v/v). The injection was 
performed using -5.0 kV potential difference across the 
capillary with a duration of 3 Seconds. Under these injection 
conditions, approximately 140 fmole of each, myoglobin 











injected into CE capillary (Joregenson and Lukacs 1983). 
The mass spectrometer was operated under a wide Scan 
range (550-1300 m/z, 2.0 sec/scan). 
FIG. 2 shows the total ion electropherogram obtained 
from the analysis of this mixture, and FIG. 3A, FIG. 3B and 
FIG. 3C show the corresponding mass Spectra. Comparison 
of the results presented in FIG. 2 and FIG. 3 with those 
previously reported for a similar mixture using sheathed 
CE/ESI-MS (Moseley et al. 1992) indicates that the 
in-capillary electrode design exhibits higher Sensitivity and 
lower background chemical noise. In addition, because of 
the in-capillary electrode design, there is no dead volume at 
the interface. 
Under the experimental conditions explained above, a 
detection limit of approximately 4 femtomoles (signal-to 
noise ratio (S/N)=3) was achieved for myoglobin. This 
detection limit is lower than Some CE-MS studies where a 
75 um-i.d. column and wide Scan range mode were used 
(Moseley et al. 1992, Banks, 1995). However, these results 
are comparable to or, in Some cases, leSS Sensitive than 
results of some other CE/ESI-MS experiments where a 
narrower capillary and/or selected ion monitoring (SIM) 
mode were used (Severs, et al. 1996, Figeys et al. 1996, 
Valaskovic et al. 1996). Considering the fact that the pres 
ently reported detection limit was achieved utilizing a 75 
tim-i.d. CE column and using a wide Scan range of m/z. 
550-1300, a considerably lower detection limit is expected 
when a narrower capillary and/or SIM mode are employed. 
5.4 Example 4 
Effects of Various Parameters on the CE/ESI-MS Interface 
The parameters investigated include the length of the Pt 
wire inside the CE capillary and its position with respect to 
the CE outlet, the effect of the epoxy used to seal the 
capillary hole and to Secure the in-capillary electrode, the 
effect of the inner diameter of the CE capillary on sensitivity 
of detection, and the effect of buffer solution pH on the 
performance of the CE/ESI-MS. The sheathless interface 
according to the present invention was further evaluated 
through the analysis of complex mixtures ranging from 
Small peptides and proteins to tryptic digests of proteins. In 
addition, the utility of this interface for the analysis of 
real-world Samples was demonstrated by analyzing whole 
human blood. 
5.4.1 Equipment 
The CE instrument used was a P/ACE System 2100 
(Beckman Instruments, Fullerton, Calif.) operating with 
Beckman System Gold software. Except when otherwise 
mentioned, the running buffer for the CE Separations was an 
aqueous 0.01 Macetic acid solution (pH=3.4). Prior to each 
Set of measurements, the capillary was conditioned with this 
buffer for 5 minutes. 
The preparation of the in-capillary electrode CE/ESI-MS 
interface as described above was followed, although thinner 
diameter wire was used for the electrode. Briefly, a 10 tim 
diameter Pt wire was inserted into a small hole near the 
outlet of the CE capillary. The hole was then sealed using 
epoxy, which also Secured the in-capillary electrode. In this 
set of experiments, 75, 50, and 30 um i.d. APS-treated 
capillaries were employed. A 50 um i.d. APS-treated CE 
capillary was used for all experiments unless otherwise 
mentioned. 
The vacuum interface to couple ESI with MS is a modi 
fied version of a previously designed vacuum interface for a 
Finnigan MAT TSQ 700 mass spectrometer (San Jose, 
Calif.). The modifications include a shorter (12 cm) heated 
capillary and the addition of a Second Stage of mechanical 
pumping Similar to the design recently reported by this 
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laboratory Jiang and Moini 1995). The mass spectrometer 
was operated in either wide Scan mode or in multiple-ion 
monitoring mode. In multiple-ion monitoring mode, 3 m/z. 
values were Selected using a mass window of 5 Da and an 
integration time of 0.30 Second (S) for each mass window. 
5.4.2 Materials 
The buffer solution (0.01 M acetic acid, pH 3.4) was 
prepared using distilled water (Barnsted NANOpure II, 
Boston, Mass.) and glacial acetic acid (Baxter Healthcare 
Corporation, McGaw Park, Ill.). The hydrochloric acid 
(HCl) and hydrofluoric acid (HF) solutions were purchased 
from Fisher Scientific Company (Fair Lawn, N.J.). Nitrogen 
gas was purchased from Wilson Oxygen & Supply Co., Inc. 
(Austin, Tex.). Modified trypsin (Promega, Madison, Wis.) 
was used for protein digestion Takada et al. 1994). All other 
chemicals including peptides, proteins, and APS were pur 
chased from Sigma Chemical Company (St. Louis, Mo.) and 
used without further purification. 
Three peptide Standard Solutions were used in these 
Studies. Two Standard Solutions (A and B) were prepared by: 
A) dissolving 2.0 mg of each peptide (AESE,362.3 DA; FV, 
264.3 Da; morphiceptin, 521.6 Da; VHLTPVEK,922.1 Da; 
bradykinin, 1060.2 Da; and cytochrome c, 12359.8Da) in 10 
mL of a methanol--water+acetic acid solution (47:47:6, V/v); 
and B) 2.5 mg of each peptide (AESE, FV, morphiceptin, 
and bradykinin) in 10 mL of the same sample. The third 
standard (C) was Sigma's HPLC peptide standard, which is 
composed of approximately 0.125 mg GY (238.2 Da), 0.5 
mg each of VYV (379.5 Da), methionine enkephalin (573.7 
Da), leucine enkephalin (555.6 Da), and angiotensin II 
(1046.2 Da). Sigma's HPLC peptide standard was dissolved 
in 1 mL. of pure water. The protein standard (standard D) 
contained 0.2 mg each of B-lactoglobulin A, ribonuclease A, 
myoglobin, lysozyme, and cytochromc c in 1 mL of 0.01 M 
acetic acid Solution. All Solutions were filtered through a 13 
mm/0.5 um syringe filter (Baxter Scientific, Grand Prairie, 
Tex.). 
The tryptic digests utilized an enzyme-to-Substrate ratio 
of approximately 1:30 in a 0.05 Mammonium bicarbonate 
(pH 8.1) solution kept at 37° C. for 16 hours. The digest was 
then dried in a vacuum centrifuge and redissolved in a 
water+methanol solution (50:50, V/v) containing 3 mM 
formic acid with an approximate Sample concentration of 50 
luM. 
Fresh human blood was obtained from a healthy adult 
male. Samples of this blood were prepared by diluting 4 till 
aliquots with 0.01% aqueous acetic acid (pH 3.4) to the 
following ratios: 1:15, 1:150; 1:1500, and 1:15000. No 
purification Step was used. These Samples were injected into 
the CE column using 1.0 psi preSSure for a duration of 3 
Seconds. ASSuming a 15 g/100 mL concentration of hemo 
globin in normal blood, the amounts of hemoglobin injected 
into CE column were approximately 10 pmol, 1 pmol, 100 
fmol, and 10 fmol, respectively, for the diluted blood. The 
blood experiments were performed on a newly acquired 
ESI/TOFMS, Mariner (PerSeptive Biosystems, Framingham 
Mass.). For this study, the mass spectrometer operated in the 
m/Z range of 500-2000 at a rate of 8000 acquisitions/second, 
which led to the generation of a Single spectrum every 
Second. 
5.4.3 Effects of the In-capillary Electrode on the Perfor 
mance of the CE Separation 
An important feature of the in-capillary electrode design 
is that there is no dead volume at the interface. As a result 
of the Pt wire inside the capillary, the inner diameter of the 
CE capillary where the Pt wire is inserted actually decreases. 











where the electrode is present, but that this reduction in no 
way reduces the capillary i.d. at its outlet end. In this Set of 
experiments, 10 um diameter Pt wires are used to construct 
the in-capillary electrodes. Use of this size wire reduces the 
i.d. of the capillary by approximately 10 um and the croSS 
sectional area of the capillary by approximately 10%. The 
actual reduction depends not only on the outer diameter of 
the Pt wire used, but also on how much the glue penetrates 
inside the capillary. Total reduction is examined by an 
experiment, Such as one reported below. This change in the 
effective i.d. of the CE capillary could be reduced by using 
a narrower wire. For example, current experimental work is 
using 1 um wire for narrower capillaries, but the following 
experimental results are based on 10 um wire. 
To investigate the effects of this partial reduction of the 
capillary i.d. on the CE Separation performance, two experi 
ments were conducted using the UV detector of the CE 
instrument at a wavelength of 214 nm. Two 75 um i.d., 80 
cm long (50 cm long from inlet to UV detector) APS-treated 
capillaries were employed, one containing an in-capillary 
electrode and one without. A 1:10 dilution of peptide stan 
dard C was used for this experiment. In both capillaries, 
Sample was injected using a pressure injection mode (0.5 
psi) with a duration of 1.2 seconds. Due to the diameter 
reduction of the capillary at the position where Pt wire was 
inserted, the amount of Sample injected into the capillary 
was approximately 80% of that injected into the capillary 
without Pt wire (FIGS. 4A and 4B). 
For this experiment, the end of the CE capillary without 
the in-capillary electrode was placed in the buffer Solution 
and the end of the capillary with the in-capillary electrode 
was grounded at the wire. A field strength of -375 V/cm was 
employed for CE Separation. Comparison between the two 
resulting UV electropherograms (FIG. 4) indicated that a 
better Separation efficiency and a slightly longer Separation 
time were obtained with the in-capillary electrode capillary 
(FIG. 4B) compared to the capillary without the in-capillary 
electrode (FIG. 4A), which are attributed to lower electroos 
motic flow (EOF) in the former capillary. 
5.4.4 Effect of Length and Position of the Electrode 
This set of experiments showed that changing the length 
of the Pt wire inside the CE capillary from approximately 
0.1 to 3.5 cm had no noticeable effects on the CE/ESI-MS 
performance. Additionally, while preliminary data indicated 
no noticeable difference in results when the hole was made 
in the range of 1.2 to 2.5 cm from the CE outlet, the latter 
experiments showed that varying the position of the hole 
where the Pt electrode is inserted into the capillary from 1 
to 4 cm also had no significant effect on CE Separation. It is 
expected that the position of this hole may be up to 10 cm 
from the outlet end without Significantly affecting CE Sepa 
ration. 
It should be noted that an electrode may also be inserted 
near the inlet end of the CE capillary. The presence of an 
in-capillary electrode near the inlet end helps to attract/inject 
ions into the capillary. This will also help to miniaturize the 
injection port of the CE and also eliminate the need for an 
external electrode in the Sample vial. 
5.4.5 Effect of Epoxy 
Since epoxy was used to Secure the Pt wire and Seal the 
hole where the Pt wire was inserted into the capillary, the 
contribution of epoxy to the background chemical noise in 
the m/z range of 250-2000 was investigated. The direct 
contact between the epoxy and the aqueous 0.01 M acetic 
acid Solution did not produce any noticeable background 
chemical noise within the mass range investigated. Because 
Some researchers add methanol to their buffer to decrease the 
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EOF, the effect of methanol on the integrity of the epoxy and 
background chemical noise was also Studied. 
The CE Separations of Standard B was compared using (1) 
a 0.01 M acetic acid buffer solution containing 10% metha 
nol; and (2) a pure 0.01 M acetic acid buffer solution. 
Approximately the Same amount of Sample was injected into 
the capillary for each analysis using a pressure injection 
mode (1.5 psi) with a duration of 3 seconds. Under these 
conditions, approximately 3.9 picomoles AESE, 5.3 pico 
moles FV, 2.7 picomoles morphiceptin, and 1.3 picomoles 
bradykinin were injected into the CE capillary. The CE was 
operated under -375 V/cm field strength. 
AS expected, the migration times of the peptides in the 
methanol-containing buffer solution increased (FIG. 5). In 
addition, a slightly better S/N was observed when methanol 
was present. However, no sign of epoxy deterioration was 
observed due to the presence of methanol. 
5.4.6 Effects of pH 
The effects of the buffer solution pH on the CE/ESI-MS 
analysis of standard A is shown in FIG. 6. Three acetic acid 
solutions at pHs 2.0, 3.4, and 5.0 were used. Approximately 
the same amount of Sample was injected into the capillaries 
for each analysis using a pressure injection mode (1.5 psi) 
with a duration of 3 Seconds (approximately 3.9 picomoles 
of AESE, 5.3 picomoles of FV, 2.7 picomoles of 
morphiceptin, 1.5 picomoles of VHLTPVEK, 1.3 picomoles 
of bradykinin, and 110 femtomoles of cytochrome c). The 
CE was operated under -375 V/cm field strength. The 
highest pH (pH 5.0), lowest ionic strength acetic acid buffer 
Solution gave the shortest retention time with the poorest 
resolution, while the lowest pH (pH 2.0), highest ionic 
strength acetic acid buffer solution showed the highest 
resolution with the longest migration time. 
5.4.7 Effect of Capillary Inner Diameter 
The effects of narrower capillaries on the sensitivity of 
detection (S/N) was also studied using the in-capillary 
electrode design. It was found that the i.d. of the capillary 
had the most significant effect on the CE/ESI-MS analyses 
of peptide and protein mixtures. A 0.5 mg/mL Solution of 
standard C (except 0.125 mg/mL GY) was used for this 
Study. Standard C was injected into both CE capillaries using 
a pressure injection mode (1.5 psi, 3 Seconds). 
A significant enhancement in the Sensitivity was observed 
as a result of the narrower capillary. The results are Sum 
marized in FIGS. 7A and 7B, where the S/N of the peptide 
mixture is compared using 50 um i.d. and 30 um id 
APS-treated capillaries. As shown in FIGS. 7A and 7B, even 
though the amount injected into the 30 um i.d capillary 
(approximately 1.9 picomoles of VYV, 0.9 picomoles of 
methionine enkephalin, 0.9 picomoles of leucine 
enkephalin, and 0.5 picomoles of angiotensin II) was only 
1/7.5 of that injected into the 50 um i.d capillary, the S/N 
obtained using the 30 um i.d. capillary was significantly 
higher than that obtained using the 50 um i.d. capillary. With 
the quantity of Sample injected here, the dipeptide (FV) was 
not detected with either capillary. 
To examine the Sensitivity of detection for proteins under 
different capillary i.d.S., the detection limits for myoglobin 
were compared using a 60 cm long, 50 um i.d. APS-treated 
capillary and a 60 cm long, 30 um i.d. APS-treated capillary. 
Under a wide scan m/z range of 500-1400, the detection 
limits for myoglobin using a 50 um i.d. and 30 um i.d. were 
approximately 1 femtomole and 600 attomoles, respectively. 
The results obtained for the 30 um i.d. capillary were 
approximately an order of magnitude better than those 
reported previously using a 75 um i.d. capillary. Compared 











one order of magnitude lower detection limit (approximately 
100 attomoles using the 50 um i.d. column) was achieved for 
both cytochrome c and myoglobin. 
5.4.8 Durability and Reproducibility 
Overall performance of CE capillaries for CE/MS analy 
sis depends on two major factors: 1) stability of the electrical 
connection at the CE outlet and 2) stability of the derivati 
Zation of the CE capillary inner wall. In-capillary electrode 
provides a robust and Stable electrical connection to the CE 
outlet for many days. However, under continuous operation 
the APS coating of the derivatized capillaries has a short 
lifetime of only a few days (2-3 days). According to our 
experience, at this time the stability of the APS derivatiza 
tion is the bottleneck and limiting factor in the performance 
of the CE for routine analysis of complex mixtures of 
peptides and proteins. The reproducibility of this CE/ESI 
MS was investigated by analyzing a 0.1 mg/mL Solution of 
gramicidin S. The relative standard deviation (RSD) of the 
height of the total ion current for five consecutive injections 
was 3.4%. For this experiment the mass spectrometer was 
Scanned in the m/z range of 552-592 at a rate of 1 Scan/Sec. 
A50 tum. 80 cm long APS-treated column, a -375 V/cm CE 
field strength, and a pressure injection (1.5 psi) mode with 
a duration of 3 Seconds were used for these experiments. 
5.4.9 Preferred Embodiment 
AS a result of the inventor's experimental work, one 
embodiment of a sheathless interface for capillary 
electrophoresis/electrospray ionization-mass spectrometry 
comprises a capillary column having a wall, an outlet end, 
and an opening in the wall. The opening is located near the 
outlet end of the capillary column. At least one electrode is 
disposed inside the capillary column through the opening in 
the wall of the capillary column. The electrode is affixed to 
that opening. The capillary column preferably has an inner 
diameter of 30 um or less, and the electrode is preferably 
platinum wire having a diameter of 10 um or leSS. The length 
of the electrode inside the capillary column is preferably 0.1 
to 3.5 cm. The opening where the electrode is inserted into 
and attached to the capillary is preferably 1 to 10 cm from 
the outlet end. If there is more than one opening, then at least 
one of the openings is close to the outlet end. The outlet end 
of the capillary column is preferably a sharp tip. This 
sheathleSS interface may optionally have an in-capillary 
electrode inserted into the capillary near its inlet end. 
5.5 Example 5 
Application of the In-capillary Electrode to Analysis of 
Proteins 
To evaluate the overall performance of the sheathless 
in-capillary electrode electrospray interface design, FIG. 8 
shows the total ion electropherogram (TIE) of protein stan 
dard D using the in-capillary electrode CE/ESI-MS sheath 
less interface. A 50 um i.d., 80 cm long APS-treated CE 
capillary was used. The CE Separation electric field Strength 
was -375 kV/cm. and the mass Spectrometer was operated 
under an m/z range of 600-2000 at 1.5 scan/sec. Approxi 
mately 200 femtomoles of each protein were injected into 
the CE capillary using a pressure injection mode (1.5 psi for 
3 seconds). The corresponding mass spectra for each peak in 
FIG. 8 is shown in FIG. 9. All proteins were resolved and 
detected in less than eight minutes. 
Complex mixtures of peptides generated from the tryptic 
digestion of large proteins present a difficult analytical 
challenge because the fragments cover a wide range of both 
pI and hydrophobicity Moseley et al. 1992). To examine the 
performance of the in-capillary electrode design with regard 
to complex mixtures generated from tryptic digests of 
proteins, tryptic digests of horse heart cytochrome c and 
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myoglobin were analyzed. For each Separation, a 0.01 M 
acetic acid buffer (pH 3.4), and a 50 um i.d., 80 cm long 
APS-treated CE capillary was used. The mass spectrometer 
was Scanned in the m/z range of 500-1100 using a Scan time 
of 1.5 scan/sec. Approximately 400 femtomoles of each 
tryptic fragments were injected into the capillary using a 
pressure injection mode (1.5 psi) with a duration of 3 
Seconds. FIGS. 10A and 10B show the total ion electro 
pherograms of the tryptic digests of horse heart cytochrome 
c and myoglobin, respectively. TABLES 1 and 2 list the main 
tryptic digest fragments of cytochrome c and myoglobin as 
well as their Sequences. 
5.6 Example 6 
Analysis of Human Blood 
Recently, matrix assisted laser desorption time-of-flight 
mass spectrometry (MALDI-TOFMS) was applied to the 
analysis of whole human blood Houston et al. 1997; Liet 
al. 1996; Lapola et al. 1997). However, no separations were 
used for these studies. In order to demonstrate the utility of 
the in-capillary electrode sheathleSS interface in the analysis 
of real-world Samples, whole human blood was analyzed 
using CE/ESI-MS. A 30 um i.d., 50 cm long APS-treated 
capillary was used for this study and the CE was operated 
under -640 V/cm field strength. The diluted blood samples 
were injected into the CE column using preSSure injection 
mode. 
FIG. 11 shows the TIE obtained from the injection of 
approximately 10 pmol, 1 pmol, 100 fmol, and 10 fmol of 
the hemoglobin in the human blood Samples. AS shown, the 
C. (15127 Da) and B (15868 Da) chains of hemoglobin were 
well separated. 
FIG. 12 shows the mass spectra of C. and 3 chains of 
hemoglobin corresponding to peaks of FIG. 11C. The Sepa 
ration achieved here for C. and B chains of hemoglobin are 
consistent or better than what was reported previously, using 
CE or CE/MS analysis of hemoglobin of single cells 
Hofstadler et al. 1995, Hofstadler et al. 1996). 
5.7 Example 7 
Time-of-Flight Mass Spectrometry for Protein Identification 
Mass spectrometry (MS) and tandem mass spectrometry 
(MS/MS) in conjunction with capillary or micro high per 
formance liquid chromatography (HPLC) or capillary elec 
trophoresis (CE) has recently become a desired technique 
for peptide mapping. Under capillary HPLC-MS or CE-MS, 
however, the peak widths resulting from Separation are 
usually very narrow (a few seconds or less). These condi 
tions require mass Spectrometers that can acquire data at a 
rapid rate. Since time-of-flight (TOF) mass spectrometers 
are capable of acquiring mass spectra at a rate Suitable for 
the analysis of these peaks, they have become the mass 
spectrometers of choice for HPLC-MS and CE-MS studies. 
For the Separation of complex biological mixtures, cap 
illary electrophoresis has several advantages over HPLC, 
including higher resolution capabilities and the ability to 
analyze Smaller Sample quantities. As a result, the combi 
nation of CE with electrospray ionization (ESI) mass spec 
trometry has proven to be applicable to a wide range of 
biologically important mixtures. For example, CE/TOF-MS 
has been Successfully applied to the analysis of Standard 
mixtures of peptides and proteins using amine-coated and 
bare, fused-Silica capillaries in conjunction with the coaxial 
sheath flow CE technique. While the coaxial sheath flow CE 
technique is the easiest way to interface CE to MS using 
electrospray ionization, during the last few years there has 
been a steady increase in the use of SheathleSS CE interfaces 











Most CE-MS analyses to date have used mass spectrom 
eters which are capable of operating with only unit mass 
resolution and low mass accuracy. This is because until 
recently only magnetic Sector and FTICR mass spectrom 
eters were capable of generating high resolution, high mass 
accuracy spectra under electrospray ionization. High 
resolution, high mass accuracy operation of these 
instruments, however, usually requires long acquisition 
times that are incompatible with the narrow peak widths 
generated by capillary electrophoresis and capillary HPLC. 
Recent advances in TOF-MS have made it possible to 
acquire high resolution (5000, based on the full width of the 
peak at half its maximum (FWHM)) and high mass accuracy 
(approximately 10 ppm) data over a wide m/z range 
(100–3000) on a short time scale (one second or less). These 
characteristics are especially useful for peptide mapping 
using capillary HPLC-MS and CE-MS in conjunction with 
a protein database Search. 
In order to identify a protein using a protein database, 
Several pieces of information are needed, including the 
average molecular weight (MW) of the protein and the 
masses of Several peptide fragments obtained through the 
enzymatic digestion of the protein of interest. The enzymatic 
digestion of proteins followed by CE-MS or HPLC-MS 
analyses of their fragments has been routinely used for 
protein identification using electrospray ionization. 
However, under ESI conditions, these peptide fragments are 
often multiply-charged, and to obtain the masses of these 
multiply-protonated peptides, one must know both the pep 
tides respective m/z's and charge States. Because the pep 
tide fragments formed under enzymatic digestions, Such as 
tryptic digestion, are usually small (<3000 Da) and their 
charge States are generally between 1 and 4, a mass Spec 
trometer with a resolving power of approximately 5000 can 
easily identify the charge States and, therefore, the molecular 
weights of these peptides. 
While knowing the molecular weights of a protein and 
Several of its peptide fragments can greatly enhance the 
chance of identifying a protein using a protein database, this 
information may not be Sufficient to uniquely identify the 
protein of interest. This is the case, for example, when 
dealing with modified proteins and/or when low Sample 
quantities are available, Such that the number of peptide 
fragments that are detectable are too few to unambiguously 
identify the protein of interest. In these situations, accurate 
mass measurements of the peptide fragments can be used as 
yet another important factor to reduce the list of most-likely 
proteins provided by a protein database and to increase the 
confidence level of the database Search results. In fact, most 
protein databases allow the user to Select error limits asso 
ciated with the masses of the protonated peptides used in the 
Search, Such that higher peptide mass accuracy corresponds 
to a shorter list of most-likely proteins. 
For the analysis of proteins of larger molecular weight, 
even the additional information about the accurate masses of 
a few peptide fragments may not be enough to uniquely 
identify an unknown protein Since different peptides may 
have the same mass. In Such cases, tandem mass spectrom 
etry (MS/MS) using in-source fragmentation is a powerful 
tool for the identification of these peptides based upon the 
total or partial determination of the amino acid Sequences of 
these peptides. However, Since Several amino acids differ in 
mass by 1-2 Da, for more accurate protein identification, it 
is ultimately desirable to use a mass spectrometer that, in the 
MS/MS mode, can easily provide the mass accuracy needed 
to distinguish these amino acids and, therefore, their corre 
sponding peptides from each other. 
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In this set of examples, the in-capillary electrode sheath 
less CE/ESI-MS interface of the present invention was 
utilized to identify horse heart cytochrome c and myoglobin 
by peptide mapping using high resolution, high mass accu 
racy TOF-MS. In addition, capillary electrophoresis in con 
junction with tandem mass spectrometry using in-Source 
fragmentation was used to determine the amino acid 
Sequences of the peptides formed through the tryptic diges 
tion of horse heart cytochrome c. 
5.7.1. Sheathless Interface 
An in-capillary electrodesheathless interface according to 
an embodiment of the present invention was prepared 
according to the above-disclosed method, using a 10 um 
diameter platinum wire for the capillary electrode. An 
aminopropyl-silane (APS)-treated, 50 um i.d., 150 um o.d., 
80 cm long CE column (Polymicro Technology, Phoenix, 
Ariz.) was used in these experiments. In all experiments, the 
outlet of the CE capillary had been sharpened by immersion 
in a 50% hydrofluoric acid (HF) solution (Fisher Scientific, 
Springfield, N.J.) for about 30 minutes while nitrogen gas 
was passed through the capillary. 
5.7.2 Materials 
Unless otherwise mentioned, all chemicals were pur 
chased from Sigma Chemical Company (St. Louis, Mo.) and 
used without further purification. The horse heart cyto 
chrome c and myoglobin were digested following the pro 
cedure reported by Takada et al. 1994). The resulting digest 
Solutions were lyophilized and redissolved in a water+ 
methanol (50/50, V/v) solution containing 3 mM formic acid 
to obtain a 9 uM final concentration. 
Three different experimental solutions were used in these 
Studies. Solution A was prepared by mixing (1:1, V/v) a 40 
uM cytochrome c (or 30 uM myoglobin) solution in 
methanol--water+acetic acid (47:47:6, V/v) with a reference 
Solution containing 1.5 uM L-methionyl-arginyl 
phenylalanyl-alanine acetate (MRFA) and 0.05% (v/v) 
Ultramark 1621 (26, 27) (PCR, Gainesville, Fla.) in 
methanol--water+acetic acid (49.5:49.5:1, v/v). Solution B 
was prepared by mixing (1:1, V/v) the previously-mentioned 
digest Solution (of cytochrome c or myoglobin) with the 
above-mentioned reference Solution. Solution C was similar 
to solution B except that 1.5 uM Ala-gly-ser-glu (AGSE) 
was used instead of MRFA as a reference compound in order 
to extend accurate mass measurement to peptides of lower 
molecular weight. 
5.7.3 Equipment 
AP/ACE System 2100 (Beckman Instruments, Fullerton, 
Calif.) CE instrument operating with Beckman System Gold 
Software and a Mariner ESI-TOF mass spectrometer 
(PerSeptive Biosystems, Inc., Framingham, Mass.) were 
used for this set of experiments. The mass spectrometer 
contains a 1 meter reflection time-of-flight mass analyzer 
which provides a resolving power of 5000 and a mass 
accuracy of approximately 10 ppm. 
Ions are generated in the electrospray ionization chamber 
and desolvated as they travel through a 25 mm long, 0.4 mm 
i.d., 6.35 mm old. heated capillary (the “nozzle”). After 
passing through a Series of skimmerS/orifices to reduce the 
presence of background neutral gases, the desolvated ions 
are focused into the ion Source push-out chamber, which 
generates ion pulses at a frequency of 8 kHz. The ions are 
then extracted from the Source and traverse the mass ana 
lyZer. Finally, the ions are detected by a microchannel-based 
detector (Galileo Electro-Optics Corp., Sturbridge, Mass.), 
and the output signal is measured by a 1 GHz time-to-digital 
COnVerter. 
The mass spectrometer is controlled by a 166 MHz 











Inc., USA). In this study, the mass spectrometer operated in 
the mass-to-charge ratio (m/z) range 500-1500 (350-1500 
for S/MS) at a rate of 8000 acquisitions/second, which led 
to the generation of a Single spectrum every Second. The 
nozzle temperature was set at 150° C. 
5.7.4 Method 
A 0.01 Macetic acid running buffer solution (pH3.4) was 
used. Between each analysis, the column was washed for 3 
minutes with methanol and then for 5 minutes with the 
running buffer. For analysis of either solution B or solution 
C, the sample was hydrodynamically injected (1.0 psi, 5 S) 
into the CE capillary (injecting approximately 1 pmol of 
each protein digest). A field strength of -398 V/cm was 
applied to the capillary for Separation while a Voltage of +1.8 
kV was applied to the in-capillary electrode to close the CE 
electric circuit and to generate the electrospray. 
The average molecular weights of the intact proteins were 
measured by continuous infusion of Solution A (containing 
either cytochrome c or myoglobin) through the CE capillary. 
The mass deconvolution Software of the Mariner was then 
used to obtain the average molecular weight of each protein 
from the ESI-MS spectra. Finnigan (San Jose., Calif.) Bio 
WorkS Software was employed to calculate the exact masses 
of each peptide and the average masses of the proteins. 
For each CE/MS analysis, solution B (containing the 
reference compounds and either the tryptic digests of cyto 
chrome c or myoglobin) was hydrodynamically injected into 
the CE inlet. For the accurate mass measurement of each 
peptide fragment and those for the two reference peaks (m/z. 
524.266 and m/z 1221.991, designated in FIG. 13 by * and 
**, respectively) were averaged to obtain a single spectrum. 
The accurate masses of the reference peaks were then used 
as internal reference masses for the accurate mass determi 
nation of the peptides. This procedure was also used for 
accurate mass measurements of collisionally-induced pep 
tide fragments except that Solution C was used and the 
instrument operated under in-Source fragmentation condi 
tions. 
5.7.5 Analysis of Horse Heart Cytochrome c and Myoglobin 
Two proteins (horse heart cytochrome c and myoglobin) 
were used as test compounds. First, the accurate average 
molecular weights of the two intact proteins were measured 
as described above using Solution A. The measured average 
molecular weights of horse heart cytochrome c and myo 
globin were 12359.2+0.5 Da (calculated mass 12359.80 Da) 
and 1695.1.0+0.5 Da (calculated mass 16951.53 Da), respec 
tively. Second, the accurate monoisotopic masses of the 
peptide fragments derived from the tryptic digestion of 
cytochrome c and myoglobin were measured by analysis of 
Solution B (containing either cytochrome c or myoglobin 
tryptic digests) using CE/ESI-MS. 
FIGS. 13A and 13B show the reconstructed ion electro 
pherograms (RIE) for the tryptic digests of cytochrome c 
and myoglobin, respectively. AS shown, all tryptic digest 
fragments of cytochrome c and myoglobin with an m/z in the 
range of 500-1500 migrated to the CE outlet and were 
detected within 10 minutes. When two or three peaks 
overlapped, the m/z of each component was easily identified 
by analysis of the maSS Spectrum of the peak. 
The results of the accurate mass measurements of the 
peptide fragments of the two proteins are listed in TABLES 
3 and 4. In most cases, the errors between the calculated and 
measured masses were less than 10 ppm. Since the experi 
ments were performed at a resolution of 5000, the charge 
state of each peptide (listed in TABLEs 3 and 4) was easily 
obtained by inspection of the isotopic spacing that defines 
the charge state of the peak of interest Senko et al. 1995). 
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The following equation provided the accurate mass of each 
protonated peptide: 
{(m/Zxcharge state)-(charge state-1)xmass of a hydrogen atom, 
1.0078 Da: 
The accurate measured masses of the protonated peptide 
fragments were then used to Search the European Molecular 
Biological Laboratory (EMBL) Protein & Peptide Group 
database (30) http://www.mann.emblheidelberg.de/ 
Services/peptideSearch/FR peptideSearch form.html. 
To Search this database, Several inputs are required includ 
ing protein MW range, digestion enzyme used, measured 
masses of the protonated peptide fragments, peptide frag 
ment mass accuracy, total number of fragments to be used 
for the database Search, and the number of peptides required 
to match. Since under the m/z range studied (500-1500) a 
total of 10 and 11 peaks were observed in these experiments 
for the cytochrome c and myoglobin digests, respectively, 
these numbers were used as the total number of peptides to 
be used for the protein database Search, and the default value 
for the MW of the protein (0-300 kDa) was used. In order 
to treat these two proteins as “unknowns” and because the 
accuracy in mass measurements of the instrument is 
approximately 10 ppm, the mass accuracy was first Set to 10 
ppm, and the number of peptides required to match was Set 
to 10 and 11 for cytochrome c and myoglobin, respectively. 
Under these conditions, the database returned no list for 
either protein, indicating that the 10 ppm mass accuracy was 
not valid for all fragments and/or that Some peptide frag 
ments were modified or contained impurities. The number of 
peptides required to match was then decreased by one until 
it reached a number at which the database was able to 
provide a list of most-likely proteins. 
The maximum values for the number of peptides required 
to match at which the database was able to return a list were 
4 for cytochrome c, and 8 for myoglobin. Under these 
conditions, the list of most-likely proteins contained only 2 
and 4 proteins for cytochrome c and myoglobin, respec 
tively. 
Under the same database search conditions but using 1000 
ppm mass error, the list of most-likely proteins contained 
>500 Suggestions for cytochrome c and 20 for myoglobin. 
Setting the maximum number of peptides required to match 
to 4 or 5 is a realistic case, especially when the Sample 
quantity is very low and only a few peaks are detectable 
using CE/ESI-MS. 
Because the accuracy of the mass spectrometer is around 
10 ppm, in the next Step, a mass accuracy of 20 ppm was 
Selected for the database search. With this, the maximum 
number of peptide masses that could be matched increased 
to 8 peptides for cytochrome c with a Single protein match 
returned by the database. The number of peptide masses that 
could be matched for myoglobin under these conditions was 
11, indicating that all of the fragments masses had been 
measured with better than 20 ppm mass accuracy, and the 
list of most-likely proteins contained 3 proteins. However, 
the calculated average molecular weight of only one of these 
three proteins matched the measured average molecular 
weight of our protein. 
Myoglobin represents an easy case in which the protein 
was unmodified, all peptide fragments were matched in the 
protein database, and the measured average MW of the 
protein matched only one of the three proteins Suggested by 
the database with an error of less than 1 Da. 
The case for cytochrome c, however, was more compli 
cated and may be more like most real-world analyses 











detected under CE/ESI-MS were matched in the database, 
indicating that the two other peaks were either impurities or 
were modified peptides. Moreover, the calculated mass of 
the most-likely protein was 657.6 Da lower than the mea 
Sured average mass of the protein of interest. Comparison 
between the experimentally-determined masses of the two 
unmatched peptide fragments (TABLE 3, peaks 1 and 10) 
and the calculated masses of the theoretically-generated 
fragments of the most-likely protein that had not already 
been paired with an experimental mass showed that peak 
number 1 was 42.010 Da greater than the N-terminus 
fragment of the most-likely protein. 
This difference corresponds to a chemical composition of 
CHO (42.011 Da), i.e., an acetyl substitution. The mass 
difference between peak 10 in TABLE 3 (m/z 817.825, 
doubly-protonated) and the only remaining theoretically 
generated fragment of the most-likely protein was 616.197 
Da, which was attributed to a heme group (616.198 Da) with 
a mass accuracy of approximately 1.6 ppm. After adding the 
molecular weights of these two modifications to the calcu 
lated mass of the most-likely protein, the corrected mass 
difference between the most-likely protein and our measured 
protein mass was less than 1 Da. The above example clearly 
shows that the mass accuracy obtained is Sufficient to obtain 
the chemical compositions of the peptides modifications. 
In Some cases, however, even knowing the accurate 
masses of a few peptide fragments may not be enough to 
uniquely identify a protein because peptides with the same 
mass could have different amino -acid Sequences. Under 
these conditions, it is desirable to obtain the Sequences of 
these peptides using tandem mass Spectrometry. It has been 
shown that even partial amino acid Sequencing can be 
enough to identify a peptide in a database Search with a high 
confidence level Mann and Wilm 1994). 
To examine the performance of the present CE/ESI-MS 
System using in-Source fragmentation for accurate amino 
acid Sequencing of peptide fragments, the CE/ESI-MS 
analysis of the tryptic digests of cytochrome c was repeated 
at an elevated nozzle-skimmer Voltage difference. Following 
CE Separation and ionization, the peptide fragments enter 
the no ZZle-skimmer region where they undergo 
collisionally-induced dissociation (CID). 
In this Study, in-Source fragmentation predominantly pro 
duced Y" (carboxyl terminus) fragmentions formed through 
amide bond cleavage. AS before, the accurate masses of the 
Y" ions of each peptide were measured with respect to 
internal references (Solution C). The results are given in 
TABLE 5. 
As shown in TABLE 5, the maximum error in mass 
measurement of the Y" ions was approximately 42 ppm. The 
accurate masses of the amino acids of each peak in this table 
can be obtained by Subtracting the measured masses of 
adjacent Y." ions. From TABLE 5, it is clear that the mass 
accuracies associated with Y" ions are well above the 
accuracies required to identify amino acids which have a 1 
or 2 mass unit difference in their molecular weights. The 
ability to differentiate between these amino acids is espe 
cially useful Since it increases the confidence level with 
which a protein identification can be achieved. 
An example of the Spectra produced under in-Source 
fragmentation using CE/ESI-tandem MS is shown in FIG. 
14, in which peak 3 of FIG. 13A (TGQAPGFTYTDANK, 
m/Z 735.856, doubly-protonated) is collisionally 
dissociated. The bold threonine in this fragment is the only 
amino acid that distinguishes Standard horse heart cyto 
chrome c from donkey/Zebra cytochrome c, where this 
threonine is replaced with a Serine. The mass difference 
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between Y" (measured mass, 711.329 Da) and Y", 
(measured mass, 812.395 Da) fragments identifies a threo 
nine residue (calculated mass, 101.047 Da). Similar results 
were also obtained for other peaks of FIG. 13A. 
5.8 Example 8 
Pressure Assisted Capillary Electrophoresis 
While CE/ESI-MS has been gaining acceptance for for 
biological research use, there have been two major obstacles 
in achieving a routine CE/ESI-MS analysis: (1) lack of a 
robust CE/ESI-MS interface; and (2) lack of a long-lasting 
derivatized CE capillary column suitable for the CE/ESI-MS 
analysis of biological mixtures. The inventors have shown 
that the robust in-capillary electrode sheathleSS interface of 
the present invention may be used for routine CE/ESI-MS 
analyses of peptides and proteins. 
However, under buffer conditions Suitable for electro 
spray ionization (Such as 0.01 M acetic acid, pH 3.4), these 
analyses require derivatization of the inner wall of the fused 
silica CE columns Cao and Moini 1997). This is because at 
a pH of approximately 3.4 the inner wall of an untreated 
fused Silica capillary column is negatively charged while 
most peptides and proteins have a net positive charge. The 
interaction of positively charged peptides and proteins with 
the negatively charged capillary wall can result in poor 
Separations or even complete analyte loSS due to absorption. 
In addition, due to the low electroosmotic flow (EOF) under 
these conditions the electrospray proceSS is not stable. 
Moreover, because of the interaction of analytes with the 
inner wall of the capillary, analysis time is usually long. 
To reduce analyte-wall interaction, Several derivatization 
methods have been introduced to chemically modify the 
inner wall of the CE capillary for CE/ESI-MS analysis 
Hjerten 1985; Cobb et al. 1990; Bruinet al. 1989; Nashabeh 
et al. 1991; Kohr et al. 1991; Ng et al. 1994; Malik et al. 
1993). One commonly used derivatization technique is the 
aminopropyl-silane (APS) treatment procedure (12-13) 
which provides good CE Separations and gives Stable elec 
trospray currents by producing high EOF of the Separation 
buffer. However, the main disadvantage associated with APS 
derivatization is that the derivatized columns have a short 
lifetime of only a few days (2-3 days). 
Researchers have used pressure assisted CE (PACE) 
analysis to solve various CE related problems U.S. Pat. 
Nos. 5,482,608 and 5,429,728; Tsuda 1992). However, the 
drawback to PACE analysis is that it reduces the CE 
separation efficiency by converting the flat flow profile of the 
liquid in the CE column into a parabolic profile Li 1992). 
The resulting decrease in peak resolution may not be accept 
able in conventional CE analyses where migration times is 
used for compound identification. In CE/ESI-MS, however, 
overlapping peaks can be easily identified based upon their 
ion electropherograms. 
The inventors have determined that the APS derivatized 
column degrades, the EOF reduces, and a make-up preSSure 
applied to the in-let of CE column is essential to achieve a 
stable electrospray. In this way, the life expectancy of APS 
treated columns can be extended greatly. 
Hemoglobin is an essential component of human physi 
ology. Abnormalities in hemoglobin can occur as a result of 
random mutations or as a defense mechanism. It is estimated 
that 150 million people worldwide carry hemoglobin 
variants, and many of these variants result in clinical mani 
festations. Therefore, the Structural characterization of 
hemoglobin is very important for the investigation of 
molecular evolution and of molecular disease due to abnor 
mal hemoglobin. A number of techniques have been devel 











variants. Usually the process of Structure characterization of 
hemoglobin is based on the analysis of tryptic digests of the 
hemoglobin chains which are separated from blood by 
means of chromatography. The peptide mapping technique 
and ion eXchange chromatography are the most popular 
methods of analysis. Recently, HPLC/ESI-MS/MS was used 
for the analysis of hemoglobin variants Lee et al. 1991; 
Covey et al. 1991). 
In this Set of experiments, the inventors analyze hemo 
globin S (HbS), a common hemoglobin variant, using PACE 
with a degraded APS treated column combined with high 
resolution, high mass accuracy TOFMS. Intact hemoglobin 
variants and their tryptic digests were Successfully analyzed 
using CE/ESI-TOFMS. Unequivocal detection of abnormal 
peptide in the tryptic digest mixture was achieved with 
tandem mass spectrometry using in-Source fragmentation. 
5.8.1. Materials 
Unless otherwise mentioned, all chemicals were pur 
chased from Sigma Chemical Company (St. Louis, Mo.) and 
used without further purification. The HbS was digested 
following the above-disclosed procedure. The digest Solu 
tion containing a 10.7 uM concentration of peptides was 
used without any treatment. 
Two different experimental Solutions, a peptide mixture 
(Solution A) and a hemoglobin digest Solution (Solution B) 
with reference compounds, were used in these Studies. 
Solution A was prepared by dissolving 2 mg of each peptide 
(Leu-gly, Val-asp, Phe-val, leu-phe, and gramicidin S) in 10 
mL of a methanol--water+acetic acid solution (47:47:6, V/v). 
Solution B was prepared by mixing (1:1, v/v) the previously 
mentioned digest solution of HbS with a reference solution 
containing 1.5 uM L-methionyl-arginyl-phenylalanyl 
alanine acetate (MRFA, MW 524.266) and Ala-gly-ser-glu 
(AGSE, MW 363.156). 
5.8.2. Equipment 
An in-capillary electrode sheathleSS interface was pre 
pared according to the above-disclosed method. Three 
degraded APS columns (after about 3 days running) were 
used in these experiments: two 75 um i.d., 150 um O.d. 
capillaries, one 66 cm long and one 110 cm long, and one 30 
tum i.d., 140 um O.d. 100 cm long capillary column 
(Polymicro Technology, Phoenix, Ariz.). In all experiments, 
the CE capillary outlet tip was sharpened by immersing the 
tip into a 50% hydrofluoric acid (HF) solution (Fisher 
Scientific, Springfield, N.J.) for about 30 minutes while N. 
gas was passed through it. 
The P/ACE System 2100 (Beckman Instruments, 
Fullerton, Calif.) CE instrument used in this study was 
capable of Simultaneously applying Voltage and preSSure 
(0.5 or 20 psi) to the inlet of the CE capillary. However, it 
did not have pressure programming capabilities, i.e., during 
Separation, the inlet pressure could not be changed continu 
ously from one pressure to another. To achieve this, the 
instrument's pressure regulator valve was adjusted using a 
screw attached to a stepping motor (Model SAS P/N 
4004-014, Hurst MFG Princeton, Ind.) and stepping motor 
controller (Model EPC-015, Hurst MFG Princeton, Ind.). 
Under these conditions, the preSSure applied to the CE inlet 
was adjustable from 0 to 6 psi. It should be understood that 
alternative means for variably controlling the inlet pressure 
during Separation can also include Software, which can be 
provided by the equipment manufacturer and that the dis 
closed variable pressure range is in no way limiting. 
Depending on the means for controlling the inlet preSSure 
during Separation, a different Set of pressure ranges can be 
achieved to Suit the user's needs. 
An electrospray ionization interface used was similar to 
that disclosed-above. A Finnigan MATTSQ 70 mass spec 
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trometer (San Jose, Calif.) with an in house fabricated 
electrospray ionization Source was used for the Study of the 
peptide mixtures. The mass spectrometer was operated in 
single ion monitoring (SIM) mode. For the study of tryptic 
digests of proteins, a PerSeptive Biosystems Mariner 
(Framingham, Mass.) electrospray ionization time-of-flight 
mass spectrometer (ESI-TOFMS) was employed. The mass 
spectrometer was operated in the m/z range of 200-1500: 
each data point on the electropherogram represents total of 
7500 acquisitions in one Second. The nozzle voltage was Set 
at 170V, except that when it was undergoing collisionally 
induced dissociation (CID), then it was set at 210V. 
Accurate mass measurements and MS/MS were done 
following the procedure Set out in the above-disclosed 
examples. Briefly, the peaks of the ion electropherogram for 
each peptide fragment and those two reference peaks (m/z. 
363.156 and m/z,524.266, designated in FIG.16 by * and **, 
respectively) were averaged to obtain a single spectrum. The 
accurate masses of the reference peaks were then used as 
internal reference masses for the accurate mass determina 
tion of the peptide. This procedure was also applied to the 
accurate mass measurements of CID peptide fragments 
which the instrument operated under in-Source fragmenta 
tion condition. 
5.8.3 Pressure Programming CE/ESI-MS 
To demonstrate the utility of preSSure programming at the 
CE inlet, a mixture containing Leu-gly, Val-asp, Phe-val, 
Leu-phe, and gramicidin S was studied. FIG. 15 shows the 
CE/ESI-MS selected ion electropherograms of the mixture's 
components under different pressure programs using 
Selected ion monitoring mode. For these experiments, five 
masses were selected using a dwell time of 0.2 seconds for 
each mass. In addition, the 110-cm-long degraded APS 
capillary column was used for a better Separation. Approxi 
mately the same amount of Sample (1 upmol each peptide) 
was hydrodynamically injected each time (1.0 psi for 5 
Seconds). A separation voltage of -30 kV was applied to the 
inlet, and +2.4 kV was applied to the electrospray electrode 
for these experiments. 
FIG. 15A shows the results obtained when 0.5 psi pres 
Sure was applied to the inlet throughout the Separation. 
Under these conditions, the total analysis time was about 50 
minutes. The peak of gramicidin S (m/z 572), the last peak 
of the reconstructed ion electropherogram (RIE), was very 
wide due to the Stronger interaction of gramicidin S with the 
capillary's inner wall. 
In FIG. 15B the applied pressure was maintained at 0.5 psi 
for the first 22 minutes. After the four dipeptides eluted from 
the column, the inlet preSSure was ramped to a final pressure 
of 3.8 psi at a rate of 0.6 psi/min, reducing the total analysis 
time to less than 30 minutes. In addition, the higher preSSure 
enhanced the signal-to-noise ratio (S/N) of the gramicidin S 
peak by decreasing its peak width. 
In FIG. 15C, the pressure programming was modified as 
follows to further reduce the analysis time: 1) for the first 6 
minutes, the pressure was increased from 0 to 2.0 psi at a rate 
of 0.33 psi/min; 2) the pressure was maintained at 2.0 psi for 
9 minutes until all four dipeptides eluted from the column; 
and 3) the pressure was then ramped to 4.0 psi at a rate of 
0.72 psi/min and kept at 4.0 psi throughout the remainder of 
the experiment. As shown in FIG.15C, the analysis time was 
further reduced to about 18 minutes. 
5.8.4 Analysis of Tryptic Digests of HbS 
The great majority of the known hemoglobin variants 
differ from their normal counterparts only by having an 
amino acid Substitution at a single position in one pair of 











Valine residue for the hydrophilic Surface residue glutamic 
acid. Therefore, the tryptic digested normal hemoglobin 
(HbA) and HbS differ in the peptides constitute the eight 
N-terminal residues of the B-subunit of Hb. Their amino acid 
Sequence are: 
HbA Val-His-Leu-Thr-Pro-Glu-Glu-Lys MW 951.503 Da 
HbS Val-His-Leu-Thr-Pro-Val-Glu-Lys MW 921.528 Da 
FIG. 16 shows the total ion electropherogram (TIE) for 
the tryptic digests of HbS using CE/ESI-TOFMS. A 30 um 
i.d. 100 cm long degraded APS column was employed for 
this study. The CE was operated under -200 V/cm field 
Strength with 3.5 psi back pressure applied at the capillary 
inlet. Approximately 200 fmol of each peptide was injected 
into CE column. 
As shown, most of the tryptic digest fragments of HbS 
with an m/z in the range of 350-1000 migrated to CE outlet 
and were detected. When two or three peaks overlapped, the 
m/Z of each component was easily identified by analysis of 
the mass spectrum of the peak. The results of the accurate 
mass measurements of the peptide fragments of the HbS are 
listed in TABLE 6. In most cases, the error between the 
calculated and measured masses were less than 10 ppm. 
FIG. 17 shows the calibrated mass spectra of the peak 16 
of FIG. 16 which corresponds to the eight N-terminal 
residue peptide of HbS. The error is less than 1 ppm. From 
the spectra, approximately 20% of the eight N-terminal 
residue peptide of HbA was also detected and the mass error 
was less than 10 ppm which indicated that there were about 
80% HbS and 20% HbA in the original HbS sample. This 
result was further confirmed by the direct infuse analysis of 
the intact HbS. 
In order to increase the confidence level associated with 
this identification, on-line in-Source fragmentation of the 
peptide of interest (VHLTPVEK, the eight N-terminal resi 
due peptide of HbS) was carried out to obtain accurate 
amino acid sequence. The CE/ESI-TOFMS analysis of the 
tryptic digests of HbS was repeated at an elevated nozzle 
Skimmer Voltage difference. Following CE Separation and 
ionization, the peptide fragments enter the nozzle-skimmer 
region where they undergo CID. 
The maSS Spectra of the eight N-terminal residue peptide 
of HbS produced under MS/MS is shown in FIG. 18 which 
corresponds to the peak 16 in FIG. 16. As before, the 
in-Source fragmentation predominantly produced Y." 
(carboxyl terminus) fragments formed through amide bond 
cleavage. The mass error for each fragment was less than 30 
ppm. The mass differences between Y" (measured mass, 
375.219 Da) and Y", (measured mass, 276.163 Da) frag 
ments identifies a valine residue (calculated mass, 99.068 Da 
and measured mass 99.056 Da, mass error 121 ppm). This 
mass accuracy is Sufficient to identify valine from any other 
amino acids. 
A detection limit for the eight N-terminal residue peptide 
of HbS was approximately 10 fmol under the experiment 
conditions used. 
6.0 CONCLUSION 
The foregoing description and illustrations contained 
herein demonstrate many of the advantages associated with 
the present invention. In particular, it has been revealed that 
the in-capillary electrode sheathleSS interface was Success 
fully applied to the CE/ESI-MS analysis of mixtures of 
Small peptides, proteins, and tryptic digests of proteins. 
Experimental variables relevant to this design, including the 
distance of the in-capillary electrode from the CE outlet and 
the length of the electrode inside the capillary, had no 
Significant effect on the CE Separation. However, Significant 
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enhancement of the Sensitivity resulted from the use of a 
narrow CE capillary. A detection limit of 600 attomoles of 
myoglobin was achieved under wide Scan m/z range of 
500-1500 using a 30 um i.d., APS-treated capillary. Under 
multiple-ion monitoring mode and using a 50 um i.d. 
APS-treated capillary, a detection limit of 100 attomoles was 
achieved for cytochrome c and myoglobin. Major tryptic 
fragments of cytochrome c and myoglobin were identified in 
less than 10 minutes and by consuming only Several nano 
liters of Sample. The interface was capable of Separating and 
detecting the major protein components of whole blood (C. 
and B hemoglobin) at 10 femtomole levels with ease. 
The resulted presented herein also demonstrate that a 
combination of (1) ESI-MS analysis of the intact protein, (2) 
CE/ESI-MS analysis of the tryptic digests of the protein 
using high mass accuracy, high resolution time-of-flight 
mass spectrometry, and (3) CE/ESI-high resolution, high 
mass accuracy tandem mass spectrometry analysis of pep 
tide fragments can uniquely characterize and Verify the 
identity of a protein of interest. 
Furthermore, the results presented herein demonstrate that 
a combination of (1) ESI-MS analysis of the intact protein; 
(2) CE/ESI-MS analysis of the tryptic digests of the protein 
using high mass accuracy, high resolution time-of-flight 
mass spectrometry; and (3) CE/ESI-high resolution, high 
mass accuracy tandem mass spectrometry analysis of pep 
tide fragments can uniquely characterize and Verify the 
identity of a protein of interest. 
Additionally, PACE technique was used to extend the life 
expectancy of APS treated columns. A common hemoglobin 
variant (HbS) was analyzed using PACE/ESI-high 
resolution, high mass accuracy TOF-MS. The results show 
that unequivocal detection of abnormal peptide in the tryptic 
digest mixture of HbS was achieved with tandem mass 
Spectrometry using in-Source fragmentation. 
Thus, it is apparent that there has been provided, in 
accordance with the invention, a novel sheathleSS interface 
for capillary electrophoresis/electrospray ionization-mass 
Spectrometry using an in-capillary electrode that Substan 
tially meets the need and advantages Set forth previously. 
Although the invention has been described and illustrated 
with reference to specific embodiments thereof, it is not 
intended that the invention be limited to these illustrative 
embodiments. Those skilled in the art will recognize that 
modifications and variations can be made without departing 
from the Spirit of the invention. For example, platinum wire 
is in no way the only available material that can be used for 
the electrode. Any conductive filament that is Suitably con 
ductive and inert to chemicals-Such as, for example, 
gold-may be used. Additionally, while epoxy was men 
tioned as the means for Sealing the hole in the capillary and 
Securing the electrode thereto, other means may be 
employed, Such as glass Seals, glass-to-metal Seals. 
Furthermore, chemical modification of the capillary column 
is in no way limited to APS derivatization. Other chemical 
modifications are envisioned to be within the spirit of the 
invention. Moreover, a SheathleSS interface having an 
in-capillary electrode according to the present invention is in 
no way limited to a Single electrode. Multiple holes along 
the length of the capillary column may be formed in the 
capillary column wall So that multiple electrodes may be 
inserted. Additionally, the capillary column may have mul 
tiple outlet ends. One way to achieve this is to make a 
capillary column that Splits into multiple legs-e.g., 
Y-shape, T-shape, football goal-shape, etc.-wherein each 
outlet end would have its own in-capillary electrode. 
It is also important to note that practice of the pressure 











invention is not limited in any way to in-capillary electrode. 
The pressure assisted method wherein the inlet preSSure is 
ramped during Separation may also be practiced with any 
type of capillary, whether or not it is chemically modified, 
degraded, has an in-capillary electrode, or has Some other 
form of electrode. One should also note that in practicing the 
invention, one is not limited to buffer solutions of any 
particular pH level. Although acidic buffer solutions were 
used in the experiments, it is envisioned that neutral and 
basic buffer Solutions may also be used for certain applica 
tions. 
Moreover, the application of the in-capillary electrode is 
not limited to capillary electrophoresis. For example, the 
in-capillary electrode can be used as an interface between 
high performance liquid chromatography and mass Spec 
trometry. Alternatively, it can also be used as a means of 
providing electrical potential to nanospray tips. Therefore, it 
is intended that this invention encompass all Such variations 
and modifications falling within the Scope of the appended 
claims. 
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TABLE 1. 




SEQ ID NO: 1) (104 amino acids, MW = 12359.8 Da 
Peak number m/z, AA sequence MW (Da) 
1. 589 Acetyl-GDVEK 1176 
2 965 EDLIAYLK 1928 
3 736 TGOAPGFTYTDANK 1470 
4 748 EETLMEYLENPK 1494 
5 678 YIPGTK 677 
6 779 MEAGIK 778 
7 634 IFVOK 633 
8 604 GITWK 603 
9 585 TGPNLHGLFGR 1168 









US 6,863,790 B1 
TABLE 5 
Measured masses of the collisionally induced fragments of tryptic digests of 











Measured Fragments m/z Error 
(fragment type, ppm error) 
375.226 (Y", 4) 
423.268 (Y", 17), 494.306 (Y", 16), 607.401 (Y"s, 31), 
720.486 (Y". 28), 835.499 (Y", 7) 
447.239 (Y", 42), 548.283 (Y"s, 27), 711.329 (Y". 3), 
812.395 (Y", 20), 959.461 (Y", 14), 1016.463 (Y", 
6), 1113.531 (Y"o 9), 1184.594 (Y", 30), 1369.631 
(Y", 6), 1470.709 (IM + HI'', 15) 
487.258 (Y", 13), 600.337 (Y"s 2), 763.397 (Y". 2), 
892.434 (Y", 8), 1023.475 (Y", 7), 1136.560 (Y", 5), 
1237.616 (Y"o. 2), 1495.649 (IM + HI'', 33) 
402.238 (Y" 7) 
no fragments detected 
374.251 (Y" 29), 521.317 (Y", 16) 
434.247 (Y", 16) 
379.212 (Y", 7), 492.306 (Y", 26), 549.331 (Y", 30), 
686,396 (Y" 33), 799.472 (Y", 18) 
375.227 (Y", 7), 476.271 (Y". 2), 613.3421 (Y", 18), 
716.351 (Y". 15), 844.408 (Y", 11), 617.202 (heme, 
7. 
TABLE 6 
Measured masses of tryptic digests of hemoglobin S in the m/z range of 350–1500. 
Peak 
number 
mfz. mfz Charge Error 
(measured) (calculated) state AA sequence (ppm) 
461.275 461.273 +1 TNVK 4.3 
531.288 532.289 +1 AAWGK 8 
765.374 765.371 +2 VGAHAGEYGAEALER 3.9 
536.28O 536.281 +2 MFLSFPTTK 8 
917.440 917.450 +2 TYFPHFDLSHGSAOVK 10.8 
4O9.731 4O9.724 +2 VDPVNFK 17 
626.855 626.862 +2 FLASVSTVLTSK 11.1 
461.772 461.772 +2 WHLTPVEK 3. 
466.765 466.764 +2 SAVTALWGK 2.1 
657.834 657.867 +2 VNVDEVGGEALGR 4.5 
637.868 637.867 +2 LLVVYPWTOR 5 
412.234 412.231 +1 AHGK 7.2 
835438 835.450 +2 VLGAFSDGLAHLDNLK 14.3 
711.341 711.341 +2 GTFATLSELEH 3. 
563.784 563.786 +2 LHVDPENFR 3.5 
689.854 689.854 +2 EFTPPVOAAYOK 3. 
575.337 575,341 +2 WVAGVANALAHK 6.9 
(1) GENERAL INFORMATION: 
SEQUENCE LISTING 
(iii) NUMBER OF SEQUENCES: 4 
(2) INFORMATION FOR SEQ ID NO: 1: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 104 amino acids 
(B) TYPE: amino acid 
(C) STRANDEDNESS: 
(D) TOPOLOGY: linear 
(ix) FEATURE: 
(A) NAME/KEY: Modified-site 
(B) LOCATION: 1 
<Unknowns 























(A) NAME/KEY: Modified-site 
(B) LOCATION22 
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-continued 
(D) OTHER INFORMATION:/note= "Lysine is linked to 
group' 
(xi). SEQUENCE DESCRIPTION: SEQ ID NO : 1 : 
Asp Val Glu Lys Gly Lys Lys Ile Phe Val Glin 
5 
His Thr Val Glu Lys Gly Gly 
Gly Lieu Phe Gly Arg Lys Thr 
35 
Asp Ala As 
50 
40 
in Lys Asn Lys Gly 
55 
Glu Tyr Lieu Glu Asn Pro Lys 
Phe Ala Gl 
70 
y Ile Lys Lys Lys 
85 
Lieu Lys Lys Ala Thr Asn. Glu 
10 O 















LENGTH: 153 amino 










(xi). SEQUENCE DESCRIPTION: SEQ ID NO: 2 
Leu Ser Asp Gly Glu Trp Glin Glin Val Lieu 
Glu Ala As 
2O 
5 
p Ile Ala Gly His 
Thr Gly. His Pro Glu Thir Leu 
35 
Lys Thr Gl 
50 
40 
u Ala Glu Met Lys 
55 
Thr Wal Wall Leu Thir Ala Leu 
His Glu Al 
70 
a Glu Lieu Lys Pro 
85 
Lys Ile Pro Ile Lys Tyr Lieu 
10 O 
Val Leu. His Ser Lys His Pro 
115 120 
Ala Met Thr Lys Ala Lieu Glu 
130 
Tyr Lys Gl 
135 
u Lieu Gly Phe Glin 
15 O 




















LENGTH: 104 amino 














































































































(A) NAME/KEY: Modified-site 
(B) LOCATION: 1 
33 
(D) OTHER INFORMATION:/note= 
acetyl-glycine' 
(ix) FEATURE: 
(A) NAME/KEY: Modified-site 
(B) LOCATION: 22 
(D) OTHER INFORMATION:/note= 
group' 
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-continued 
'Glycine equals 
'Llysine is linked to 



















































(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 
(B) TYPE: amino acid 
(C) STRANDEDNESS: 
















(xi). SEQUENCE DESCRIPTION: SEQ ID NO: 4 
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What is claimed is: 
1. A method for chemically analyzing a chemical or 
biological Sample using capillary electrophoresis/ 
electrospray ionization-mass spectrometry, comprising the 
Steps of: 
providing a capillary column having a wall and at least 
one electrode inside the capillary column, the at least 
one electrode being attached via an opening in the wall 
of the capillary column and extending longitudinally 
within the capillary column; 
providing a mass spectrometer in operable relation to the 
capillary column; 
applying a Voltage potential across the capillary column; 
injecting a mixture containing the chemical or biological 
Sample into the capillary column; 
transporting at least a portion of the mixture to the mass 
Spectrometer; and 
analyzing the portion with the mass Spectrometer to 
identify the composition of the chemical or biological 
Sample in the portion. 
2. The method of claim 1, further comprising the step of: 
preconditioning the capillary column with a buffer Solu 
tion prior to the Step of injecting the mixture. 
3. The method of claim 1, further comprising the steps of: 
maintaining an inlet pressure at a first preSSure level at an 
inlet end of the capillary column for a first period of 
time; 
ramping the inlet pressure to a Second pressure level once 
at least a portion of the mixture containing the chemical 





maintaining the inlet pressure at the Second pressure level 
for a Second period of time. 
4. The method of claim3, wherein the step of ramping the 
inlet pressure increases the inlet pressure at a rate of constant 
acceleration. 
5. The method of claim3, wherein the step of ramping the 
inlet pressure increase the inlet pressure at a variable rate of 
acceleration. 
6. The method of claim 1, further comprising the steps of: 
maintaining an inlet pressure at a first pressure level at an 
inlet end of the capillary column for a first period of 
time; 
ramping the inlet preSSure to a Second pressure level once 
at least a portion of the mixture containing the chemical 
or biological Sample has eluted from the capillary 
column; 
maintaining the inlet pressure at the Second pressure level 
for a Second period of time, 
and 
ramping the inlet preSSure to a third pressure level once 
the Second period of time has elapsed. 
7. The method of claim 6, wherein the step of ramping the 
inlet pressure to the Second pressure level or the Step of 
ramping the inlet pressure to the third pressure level 
increases the inlet preSSure at a rate of constant acceleration. 
8. The method of claim 6, wherein the step of ramping the 
preSSure to the third preSSure level is performed at a higher 
acceleration rate than the Step of ramping the pressure to the 
Second pressure level. 
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